EcoDrugPlus

Progesterone Receptor

Ensembl ID : ENSCVAG00000023425
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSCVAG00000017767
Gene Symbol: PTGDR2
4 Cross references
134 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSCVAG00000002917
Gene Symbol: PTGDR2
1 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSCVAG00000007975
Gene Symbol: PTGER2
3 Cross references
203 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSCVAG00000011464
Gene Symbol: PTGER3
3 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSCVAG00000020584
Gene Symbol: PTGER4
3 Cross references
202 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSCVAG00000011306
Gene Symbol: LOC107096617
3 Cross references
171 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSCVAG00000007784
Gene Symbol: LOC107087666
3 Cross references
163 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSCVAG00000001289
Gene Symbol: LOC107102724
3 Cross references
202 Possible Orthologues:

Prostaglandin F2-Alpha Receptor-Like

Ensembl ID : ENSCVAG00000003328
Gene Symbol: LOC107081969
3 Cross references
195 Possible Orthologues:

Prostaglandin G/h Synthase 1-Like

Ensembl ID : ENSCVAG00000021331
Gene Symbol: LOC107098100
2 Cross references
196 Possible Orthologues:

Prostaglandin G/h Synthase 1-Like

Ensembl ID : ENSCVAG00000022549
Gene Symbol: LOC107088990
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).